For the quarter ending 2025-09-30, DVAX made $94,876K in revenue. $26,927K in net income. Net profit margin of 28.38%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenues | 94,876 | 95,442 | 68,164 | 35,356* |
| Cost of sales - product | 14,403 | 14,035 | 13,769 | 10,193* |
| Research and development | 19,116 | 16,619 | 19,377 | 18,341* |
| Selling, general and administrative | 40,086 | 50,359 | 47,678 | 44,044* |
| Bad debt expense | 0 | 0 | 10,970 | - |
| Total operating expenses | 73,605 | 81,013 | 91,794 | 72,578* |
| Sublease income | - | - | - | 1,254* |
| Income (loss) from operations | 21,271 | 14,429 | -23,630 | -37,222* |
| Interest income | 6,593 | 6,798 | 7,739 | 8,318* |
| Interest expense | 1,643 | 1,641 | 1,692 | 1,697* |
| Sublease income | 2,225 | 2,226 | 2,226 | - |
| Loss on debt extinguishment | 0 | 0 | -82,095 | - |
| Other loss | -27 | -596 | -423 | 749* |
| Net income (gain) before income taxes | 28,419 | 21,216 | -97,875 | -28,599* |
| Provision for income taxes | 1,492 | 2,495 | -1,776 | -3,126* |
| Net income (gain) | 26,927 | 18,721 | -96,099 | -25,473 |
| Net (loss) income allocable to common stockholders, basic (in usd per share) | - | - | - | -25,473 |
| Basic EPS | 0.23 | 0.16 | -0.77 | -0.198 |
| Diluted EPS | 0.21 | 0.14 | -0.77 | -0.228 |
| Basic Average Shares | 117,307,000 | 119,317,000 | 124,871,000 | 128,961,000 |
| Diluted Average Shares | 136,468,000 | 138,356,000 | 124,871,000 | 111,881,000 |
DYNAVAX TECHNOLOGIES CORP (DVAX)
DYNAVAX TECHNOLOGIES CORP (DVAX)